Pesampator
id:
pesampator-180-15777361
title:
Pesampator
text:
Pesampator is a positive allosteric modulator (PAM) of the AMPA receptor (AMPAR), an ionotropic glutamate receptor, which was under development by Pfizer for the treatment of cognitive symptoms in schizophrenia. In March 2018, the development of the drug was transferred over from Pfizer to Biogen. It was also under development for the treatment of age-related sensorineural hearing loss, but development for this indication was terminated due to insufficient effectiveness. In July 2022, Biogen dis
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Pesampator
date created:
2017-08-30T15:22:05Z
date modified:
2024-09-05T15:04:07Z
main entity:
{"identifier":"Q27272515","url":"https://www.wikidata.org/entity/Q27272515"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/85/BIIB-104.svg","width":512,"height":265}
fields total:
13
integrity:
16